DE NOVO MYELODYSPLASTIC SYNDROME
Clinical trials for DE NOVO MYELODYSPLASTIC SYNDROME explained in plain language.
Never miss a new study
Get alerted when new DE NOVO MYELODYSPLASTIC SYNDROME trials appear
Sign up with your email to follow new studies for DE NOVO MYELODYSPLASTIC SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug cocktail aims to boost remission in leukemia patients
Disease control Recruiting nowThis study tests a combination of five drugs (fludarabine, cytarabine, filgrastim-sndz, gemtuzumab ozogamicin, and idarubicin) in 270 adults with newly diagnosed acute myeloid leukemia or high-risk myelodysplastic syndrome that have specific genetic changes. The goal is to see ho…
Matched conditions: DE NOVO MYELODYSPLASTIC SYNDROME
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 26, 2026 07:58 UTC
-
New combo therapy aims to boost blood cells in bone marrow failure diseases
Disease control Recruiting nowThis study tests a combination of drugs to help people with aplastic anemia or low-risk myelodysplastic syndrome (MDS) who have dangerously low blood counts. The treatment includes horse anti-thymocyte globulin (hATG) and cyclosporine to calm the immune system, plus steroids and …
Matched conditions: DE NOVO MYELODYSPLASTIC SYNDROME
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 26, 2026 07:56 UTC
-
New drug cocktail shows promise for tough blood cancers
Disease control Recruiting nowThis study tests a combination of four chemotherapy drugs (cladribine, idarubicin, cytarabine, and venetoclax) in about 500 adults with acute myeloid leukemia, high-risk myelodysplastic syndrome, or blast-phase chronic myeloid leukemia. The goal is to see how well these drugs kil…
Matched conditions: DE NOVO MYELODYSPLASTIC SYNDROME
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 26, 2026 07:26 UTC